ZTS
Zoetis Inc.NYSEResearch view
Healthcare · Pharmaceutical Preparations · Large-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$29.5B
Enterprise Value$36.1B
Income$2.7B
Sales$9.5B
Book/sh$8.26
Cash/sh$5.93
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio1.98
Current Ratio3.12
Debt/Eq2.65
EPS (ttm)$6.02
EPS this Y10.1%
EPS past 3/5Y10.3%
Sales past 3/5Y5.4%
EPS Y/Y TTM10.1%
Sales Y/Y TTM2.3%
Shs Outstand413.22M
ROA17.3%
ROE78.3%
ROIC—
Gross Margin—
Oper. Margin—
Profit Margin28.2%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$7.8B
2021
$8.1B
2022
$8.5B
2023
$9.3B
2024
$9.5B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $7.8B | $8.1B | $8.5B | $9.3B | $9.5B |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | $2.0B | $2.1B | $2.3B | $2.5B | $2.7B |
| Diluted EPS | $4.27 | $4.49 | $5.07 | $5.47 | $6.02 |
| Operating Cash Flow | $2.2B | $1.9B | $2.4B | $3.0B | $2.9B |
| Free Cash Flow | $1.7B | $1.3B | $1.6B | $2.3B | $2.3B |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $621.0M against $2.9B operating cash
COMMUNITY · $ZTS0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Pharmaceutical Preparations
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.